Abstract:Voltage-gated Ca2+ channels play essential roles in control of neurosecretion and muscle contraction. The pharmacological significance of Cav channels stem from their identification as the molecular targets of calcium blockers used in the treatment of cardiovascular diseases, such as hypertension, angina, and arrhythmia, and neurologic diseases, such as pain and seizure. It has been proposed that state-dependent Cav inhibitors, that is, those that preferentially bind to channels in open or inactivated states, may improve the therapeutic window over relatively state-independent Cav inhibitors. High-throughput fluorescent-based functional assays have been useful in screening chemical libraries to identify Cav inhibitors. However, hit confirmation, mechanism of action, and subtype selectivity are better suited to automated patch clamp assays that have sufficient capacity to handle the volume of compounds identified during screening, even of modest sized libraries (≤500,000 compounds), and the flexible voltage control that allows evaluation of state-dependent drug blocks. IonWorks Barracuda (IWB), the newest generation of IonWorks instruments, provides the opportunity to accelerate the Cav drug discovery studies in an automated patch clamp platform in 384-well format capable of medium throughput screening and profiling studies. We have validated hCav1.2, hCav2.1, hCav2.2, and hCav3.2 channels assays on the IWB platform (population patch clamp mode) and demonstrated that the biophysical characteristics of the channels (activation, inactivation, and steady-state inactivation) obtained with the IWB system are consistent with known subtype-specific characteristics. Using standard reference compounds (nifedipine, BAY K8644, verapamil, mibefradil, and pimozide), we demonstrated subtype-selective and state- and use-dependent characteristics of drug-channel interactions. Here we describe the design and validation of novel robust high-throughput Cav channel assays on the IWB platform. The assays can be used to screen focused compound libraries for state-dependent Cav channel antagonists, to prioritize compounds for potency or to counterscreen for Cav subtype selectivity.

Fluorescence-Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines

Automated Tight Seal Electrophysiology for Assessing the Potential Herg Liability of Pharmaceutical Compounds

Identification of Small-Molecule Ion Channel Modulators in C. Elegans Channelopathy Models.

Novel screening techniques for ion channel targeting drugs

Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening

Fluorescence Thermal Shift Assay based High Through-put Screening in Small Molecule Drug Discovery: A Brief Overview

Ultrasensitive Liposome-Based Assay for the Quantification of Fundamental Ion Channel Properties.

Targeting ion channels with ultra-large library screening for hit discovery

Electrical Impedance Spectroscopy for Drug Screening on Ligand-Gated Ion Channels

Development and Application of Activity-based Fluorescent Probes for High-Throughput Screening

High-throughput and Automated Anion Transport Assays

Application of large-scale transiently transfected cells to functional assays of ion channels: different targets and assay formats.

An efficient and information-rich biochemical method design for fragment library screening on ion channels

The Patch-Clamp Array Technologies and Their Application in Pharmaceutical Screening

Computer-Aided Drug Discovery and Design Targeting Ion Channels.

Application of large-scale transient transfection to cell-based functional assays for ion channels and GPCRs.

A thallium transport FLIPR-based assay for the identification of KCC2-positive modulators

Evaluating State Dependence and Subtype Selectivity of Calcium Channel Modulators in Automated Electrophysiology Assays

High-throughput Electrophysiological Assays for Voltage Gated Ion Channels Using SyncroPatch 768PE.

Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective

High throughput clone screening on overexpressed hERG1 and Kv1.3 potassium channels using ion channel reader (ICR) label free technology